Rx to Go LLC, the in-house specialty pharmacy for Florida Cancer Specialists & Research Institute LLC (FCS), announced on Tuesday that it has received re-accreditation through Accreditation Commission for Health Care (ACHC) for pharmacy services with distinction in oncology through November 2028.
In the accreditation process, healthcare organisations must demonstrate compliance with national standards. Accreditation by ACHC reflects an organisation's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care, Rx to Go said.
Rx To Go also has accreditation by URAC for Specialty Pharmacy and is dually accredited by the National Association of Boards of Pharmacy (NABP) for specialty pharmacy. FCS is also NABP accredited for digital pharmacy practice.
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA